Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis

Medicine (United States)

Volumn 96, Issue 39, 2017, Pages

  Dai, Wenjie ^a   Ye, Ling ^b   Liu, Aizhong ^a   Wen, Shi Wu ^a,c,d   Deng, Jing ^a   Wu, Xin ^a   Lai, Zhiwei ^e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF OTTAWA   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e Hunan Provincial Center for Disease Control and Prevention   (China)

Author keywords

meta analysis; nonalcoholic fatty liver disease; prevalence; type 2 diabetes mellitus

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; CNKI DATABASE; DYSLIPIDEMIA; EMBASE; GENDER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WANFANG DATABASE; WEB OF SCIENCE; COMPLICATION; DISEASE MANAGEMENT; EARLY DIAGNOSIS; NEEDS ASSESSMENT; NON-ALCOHOLIC FATTY LIVER DISEASE;

DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EARLY DIAGNOSIS; HUMANS; NEEDS ASSESSMENT; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE;

EID: 85030780032     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000008179     Document Type: Article

References (56)

1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84.
2. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21.
3. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23.
4. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
5. Forlani G, Giorda C, Manti R, et al. The burden of NAFLD and its characteristics in a nationwide population with type 2 diabetes. J Diabetes Res 2016;2016:2931985.
6. Portillo-Sanchez P, Bril F, Maximos M, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab 2015;100:2231-8.
7. Leite NC, Villela-Nogueira CA, Pannain VL, et al. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int 2011;31:700-6.
8. Younossi ZM, Gramlich T, Matteoni CA, et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004;2:262-5.
9. Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30:2119-21.
10. Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008;51:444-50.
11. Almobarak AO, Barakat S, Suliman EA, et al. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit? Arab J Gastroenterol 2015;16:54-8.
12. Williamson RM, Price JF, Glancy S, et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011;34:1139-44.
13. Alharbi NS, Almutari R, Jones S, et al. Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: systematic review and meta-analysis. Diabetes Res Clin Pract 2014;106:e30-3.
14. Yi M, Chen RP, Yang R, et al. Increased prevalence and risk of nonalcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China. Diabetic Med 2017;34:505-13.
15. Dvorak K, Hainer R, Petrtyl J, et al. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. Biomed Pap 2015;159:442-8.
16. Leite NC, Salles GF, Araujo ALE, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009;29:113-9.
17. Chen X, Li L, Zhou T, et al. Prevalence of hypertension in rural areas of china: a meta-analysis of published studies. PloS One 2014;9:e115462.
18. Ho NS, Olds T, Schranz N, et al. Secular trends in the prevalence of childhood overweight and obesity across Australian states: A metaanalysis. J Sci Med Sport 2017;20:480-8.
19. Tabatabaei-Malazy O, Qorbani M, Samavat T, et al. Prevalence of dyslipidemia in Iran: a systematic review and meta-analysis study. Int J Prev Med 2014;5:373-93.
20. Yang LS, Zhang ZH, Sun L, et al. Prevalence of suicide attempts among college students in China: a meta-analysis. PloS One 2015;10:e0116303.
21. Hu J, Dong Y, Chen X, et al. Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatr 2015;61:78-89.
22. Ades AE, Lu G, Higgins JP. The interpretation of random-effects metaanalysis in decision models. Med Decis Making 2005;25:646-54.
23. Li Y, Li Y, Cao J. Factors associated with suicidal behaviors in mainland China: a meta-analysis. BMC Public Health 2012;12:524.
24. Han C, Zhang M, Luo X, et al. Secular trends in the prevalence of type 2 diabetes in adults in China from 1995 to 2014: a meta-analysis. J Diabetes 2017;9:450-61.
25. Dai W, Chen L, Lai Z, et al. The incidence of post-traumatic stress disorder among survivors after earthquakes: a systematic review and meta-analysis. BMC Psychiatr 2016;16:188.
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
27. He Q, Peng WJ, Zhang JQ, et al. Prevalence of unprotected anal intercourse and unprotected vaginal intercourse among HIV-positive men who have sex with men in China: ameta-analysis. Sex Transm Infect 2012;88:229-33.
28. Lu H, Zeng L, Liang B, et al. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res 2009;40:571-5.
29. Lv W-S, Sun R-X, Gao Y-Y, et al. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol 2013;19:3134-42.
30. Targher G, Mantovani A, Pichiri I, et al. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with Type 2 diabetes. Clin Sci 2013;125:301-9.
31. Kim S-K, Choi YJ, Huh BW, et al. Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab 2014;99:1879-84.
32. Zhan Y-T, Zhang C, Li L, et al. Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in type 2 diabetes. Int J Mol Sci 2012;13:14698-706.
33. Kalra S, Vithalani M, Gulati G, et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India 2013;61:448-53.
34. Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007;30:1212-8.
35. Sima A, Timar R, Vlad A, et al. Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients. Wien Klin Wochenschr 2014;126:335-40.
36. Mantovani A, Rigamonti A, Bonapace S, et al. Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour Holter monitoring. Diabetes Care 2016;39:1416-23.
37. Guo K, Zhang L, Lu J, et al. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. J Diabetes Complications 2017;31:80-5.
38. Fan N, Zhang L, Xia Z, et al. Sex-specific association between serum uric acid and nonalcoholic fatty liver disease in type 2 diabetic patients. J Diabetes Res 2016;2016:3805372.
39. Ding X, Xu Y, Wang Y, et al. Nonalcoholic fatty liver disease and associated metabolic risks of hypertension in type 2 diabetes: a crosssectional community-based study. Int J Endocrinol 2017;2017:526256.
40. Kim BY, Jung CH, Mok JO, et al. Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with nonalcoholic fatty liver disease. J Diabetes Invest 2014;5:170-5.
41. Silaghi CA, Silaghi H, Craciun AE, et al. Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. Med Ultrason 2015;17:300-7.
42. Li W, Xiang H, Ding DWX, et al. The clinical analysis of nonalcoholic fatty liver and its correlation factors in type 2 diabetes mellitus. Chin J Diabetes 2006;14:35-6.
43. Zhao L, Shrestha D, Zhang X, et al. A retrospective clinical analysis of prevalence of non-alcoholic fatty liver disease in inpatients with type 2 diabetes mellitus. Chin J Diabetes 2008;16: 535, 562.
44. Wu JC, Li XH, Peng YD, et al. Non-alcoholic fatty liver disease is associated with chronic kidney disease and diabetic retinopathy in type 2 diabetic patients. Chin J Pract Intern Med 2010;30:41-3.
45. Li MZ, Hao JY, Sun LR. Relationship between serum uric acid and nonalcoholic fatty liver in patients with type 2 diabetes. Chin J Endocrinol Metab 2012;28:215-6.
46. Li YJ, Su HY, Li SQ. Prevalence and characteristics of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Guangxi Med J 2012;34:86-8.
47. Shang HX, Li H, Yang ZG, et al. Associations between nonalcoholic fatty liver disease and renal injury in patients with type 2 diabetes. JMed Forum 2014;35:10-2.
48. Li CX, Liu JF, Shi L, et al. Risk factors of non-alcoholic fatty liver disease in patients with incipient type 2 diabetes mellitus. Guangxi Med J 2015;37:973-5.
49. Steffensen C, Pereira AM, Dekkers OM, et al. Diagnosis of endocrine disease: prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol 2016;175: R247-53.
50. Edridge CL, Dunkley AJ, Bodicoat DH, et al. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PloS One 2015;10:e0126427.
51. Ali S, Stone MA, Peters JL, et al. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Med 2006;23:1165-73.
52. Adeloye D, Ige JO, Aderemi AV, et al. Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ Open 2017;7:e015424.
53. Lazo M, Hernaez R, EberhardtMS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2013;178:38-45.
54. Moon SS. Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre-and postmenopausal women. Ann Nutr Metab 2013;62:158-63.
55. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986;292:13-5.
56. Liu JQ, Zhang ZJ, Wang W, et al. Risk factors for non-alcoholic fatty liver disease combined with type 2 diabetes mellitus in adolescents. World Chin J Digestol 2015;23:1812-7.